124 related articles for article (PubMed ID: 28063664)
1. Hesperetin-etoposide combinations induce cytotoxicity in U2OS cells: Implications on therapeutic developments for osteosarcoma.
Coutinho L; Oliveira H; Pacheco AR; Almeida L; Pimentel F; Santos C; Ferreira de Oliveira JM
DNA Repair (Amst); 2017 Feb; 50():36-42. PubMed ID: 28063664
[TBL] [Abstract][Full Text] [Related]
2. Combination of etoposide and fisetin results in anti-cancer efficiency against osteosarcoma cell models.
Ferreira de Oliveira JMP; Pacheco AR; Coutinho L; Oliveira H; Pinho S; Almeida L; Fernandes E; Santos C
Arch Toxicol; 2018 Mar; 92(3):1205-1214. PubMed ID: 29270805
[TBL] [Abstract][Full Text] [Related]
3. Interferonalpha enhances etoposide-induced apoptosis in human osteosarcoma U2OS cells by a p53-dependent pathway.
Yuan XW; Zhu XF; Liang SG; Fan Q; Chen ZX; Huang XF; Sheng PY; He AS; Yang ZB; Deng R; Feng GK; Liao WM
Life Sci; 2008 Feb; 82(7-8):393-401. PubMed ID: 18191951
[TBL] [Abstract][Full Text] [Related]
4. Taxol in combination with doxorubicin or etoposide. Possible antagonism in vitro.
Hahn SM; Liebmann JE; Cook J; Fisher J; Goldspiel B; Venzon D; Mitchell JB; Kaufman D
Cancer; 1993 Nov; 72(9):2705-11. PubMed ID: 8104682
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of the third-generation bisphosphonate risedronate alone and in combination with anticancer drugs against osteosarcoma cell lines.
Murayama T; Kawasoe Y; Yamashita Y; Ueno Y; Minami S; Yokouchi M; Komiya S
Anticancer Res; 2008; 28(4B):2147-54. PubMed ID: 18751388
[TBL] [Abstract][Full Text] [Related]
6. Inorganic phosphate enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin via a p53-dependent pathway.
Spina A; Sorvillo L; Di Maiolo F; Esposito A; D'Auria R; Di Gesto D; Chiosi E; Naviglio S
J Cell Physiol; 2013 Jan; 228(1):198-206. PubMed ID: 22674530
[TBL] [Abstract][Full Text] [Related]
7. Effects of etoposide alone and in combination with piroxicam on canine osteosarcoma cell lines.
Ong SM; Saeki K; Tanaka Y; Nishimura R; Nakagawa T
Vet J; 2016 Dec; 218():51-59. PubMed ID: 27938709
[TBL] [Abstract][Full Text] [Related]
8. The apoptotic effect of hesperetin on human cervical cancer cells is mediated through cell cycle arrest, death receptor, and mitochondrial pathways.
Alshatwi AA; Ramesh E; Periasamy VS; Subash-Babu P
Fundam Clin Pharmacol; 2013 Dec; 27(6):581-92. PubMed ID: 22913657
[TBL] [Abstract][Full Text] [Related]
9. Phosphatidylinositol 3-kinases inhibitor LY294002 potentiates the cytotoxic effects of doxorubicin, vincristine, and etoposide in a panel of cancer cell lines.
Badinloo M; Esmaeili-Mahani S
Fundam Clin Pharmacol; 2014 Aug; 28(4):414-22. PubMed ID: 23837575
[TBL] [Abstract][Full Text] [Related]
10. Fisetin and hesperetin induced apoptosis and cell cycle arrest in chronic myeloid leukemia cells accompanied by modulation of cellular signaling.
Adan A; Baran Y
Tumour Biol; 2016 May; 37(5):5781-95. PubMed ID: 26408178
[TBL] [Abstract][Full Text] [Related]
11. [p33(ING1b) enhances chemosensitivity of osteosarcoma cell U2OS to etoposide].
Zhu JJ; Liao WM; Li FB; Zhu XF; Zhou JM; Liu ZC
Ai Zheng; 2004 Jun; 23(6):640-4. PubMed ID: 15191662
[TBL] [Abstract][Full Text] [Related]
12. p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression.
Novello C; Pazzaglia L; Conti A; Quattrini I; Pollino S; Perego P; Picci P; Benassi MS
PLoS One; 2014; 9(12):e114757. PubMed ID: 25490093
[TBL] [Abstract][Full Text] [Related]
13. E2F-1 overexpression in U2OS cells increases cyclin B1 levels and cdc2 kinase activity and sensitizes cells to antimitotic agents.
Russo AJ; Magro PG; Hu Z; Li WW; Peters R; Mandola J; Banerjee D; Bertino JR
Cancer Res; 2006 Jul; 66(14):7253-60. PubMed ID: 16849574
[TBL] [Abstract][Full Text] [Related]
14. Synergistic cytotoxic effects of inorganic phosphate and chemotherapeutic drugs on human osteosarcoma cells.
Spina A; Sorvillo L; Chiosi E; Esposito A; Di Maiolo F; Sapio L; Caraglia M; Naviglio S
Oncol Rep; 2013 May; 29(5):1689-96. PubMed ID: 23446517
[TBL] [Abstract][Full Text] [Related]
15. Chlorogenic Acid Enhances Doxorubicin-Mediated Cytotoxic Effect in Osteosarcoma Cells.
Salzillo A; Ragone A; Spina A; Naviglio S; Sapio L
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445291
[TBL] [Abstract][Full Text] [Related]
16. The administration schedule of cyclin-dependent kinase inhibitor gene therapy and etoposide chemotherapy is a major determinant of cytotoxicity.
Prabhu NS; Somasundaram K; Tian H; Enders GH; Satyamoorthy K; Herlyn M; El-Deiry WS
Int J Oncol; 1999 Aug; 15(2):209-16. PubMed ID: 10402229
[TBL] [Abstract][Full Text] [Related]
17. Intensified Chemotherapy With Dexrazoxane Cardioprotection in Newly Diagnosed Nonmetastatic Osteosarcoma: A Report From the Children's Oncology Group.
Schwartz CL; Wexler LH; Krailo MD; Teot LA; Devidas M; Steinherz LJ; Goorin AM; Gebhardt MC; Healey JH; Sato JK; Meyers PA; Grier HE; Bernstein ML; Lipshultz SE
Pediatr Blood Cancer; 2016 Jan; 63(1):54-61. PubMed ID: 26398490
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1 alpha increases the cytotoxic activity of etoposide against human osteosarcoma cells.
Jia SF; Zwelling LA; McWatters A; An T; Kleinerman ES
J Exp Ther Oncol; 2002; 2(1):27-36. PubMed ID: 12415617
[TBL] [Abstract][Full Text] [Related]
19. The p33ING1b tumor suppressor cooperates with p53 to induce apoptosis in response to etoposide in human osteosarcoma cells.
Zhu JJ; Li FB; Zhu XF; Liao WM
Life Sci; 2006 Feb; 78(13):1469-77. PubMed ID: 16325212
[TBL] [Abstract][Full Text] [Related]
20. Niclosamide inhibits the proliferation of human osteosarcoma cell lines by inducing apoptosis and cell cycle arrest.
Li Z; Yu Y; Sun S; Qi B; Wang W; Yu A
Oncol Rep; 2015 Apr; 33(4):1763-8. PubMed ID: 25634333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]